«Lung health has never been more of a priority for our world than it is right now. Even prior to the Covid-19 pandemic, the incidence of life-threatening lung disease was consistently on the rise. These conditions are difficult to diagnose, contribute significantly to healthcare costs, and diminish quality of life for patients.»

«When you consider the facts about lung disease, the case becomes clear for greater precision in the diagnosis and treatment of these conditions. Case in point: The cost of care for the 37 million Americans who are living with chronic lung disease is substantial, with U.S. workers paying $7 billion for asthma treatment from 2011-2015 and $5 billion for treatment of COPD. An estimated 236,740 new cases of lung cancer will be diagnosed in the United States in 2022, and 1-in-16 people will get lung cancer in their lifetime. Meanwhile, there are more than 200 forms of interstitial lung disease (ILD), and 55% of people with ILD (interstitial lung diseases) receive at least one misdiagnosis, while 38% receive two or more misdiagnoses prior to an accurate diagnosis.»

Article written by Auriane Oliver



MedCity News